Phio Pharmaceuticals Corp (PHIO)

Phio Pharmaceuticals Corp (PHIO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $10.9M; returns 1 day -2.3%, 1 week -2.1%, 1 year -60.2%.

Phio Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company focused on developing novel immuno-oncology therapeutics using its proprietary INTASYL® gene silencing technology. The company's core approach involves self-delivering, chemically modified siRNA compounds designed to silence specific genes that enable tumors to evade the immune system.

Groups PHIO belongs to

• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Healthcare
• Oncology
• Gene Therapy
• Immunotherapy
• Cancer Therapeutics
• PD-L1
• R&D

PHIO financial model: income statement, cash flow and balance sheet